| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $4.7B | $4.2B | $3.8B | $3.9B | $3.7B | $3.6B | $3.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.9B | $0.4B | $0.3B | $0.3B | $0.2B | $0.3B | $0.2B | $0.2B |
| Net Income | $1.1B | $0.2B | $0.2B | $0.1B | $0.6B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $5.69 | $1.22 | $0.88 | $0.81 | $3.55 | $0.80 | $0.54 | $0.62 |
| EPS (Diluted) | $5.69 | $1.22 | $0.88 | $0.81 | $3.55 | $0.80 | $0.54 | $0.62 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $35.4B | $32.8B | $30.3B | $27.8B | $26.1B | $24.8B | $22.7B | $21.2B |
| Current Assets | $2.2B | $1.2B | $1.4B | $1.3B | $1.6B | $1.9B | $1.3B | $0.8B |
| Cash & Equivalents | $0.1B | $0.1B | $0.3B | $0.1B | $0.1B | $0.5B | $0.1B | $0.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.7B | $3.1B | $2.2B | $2.8B | $2.1B | $2.9B | $2.0B | $2.1B |
| Stockholders' Equity | $10.8B | $10.3B | $9.8B | $7.7B | $7.3B | $6.5B | $6.1B | $5.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.1B | $2.0B | $1.9B | $1.1B | $1.4B | $1.4B | $1.4B | $1.4B |
| Investing Cash Flow | $-3.3B | $-3.4B | $-2.8B | $-2.1B | $-1.5B | $-2.1B | $-1.9B | $-2.0B |
| Capital Expenditures | $3.1B | $2.9B | $2.6B | $2.3B | $1.8B | $1.8B | $1.7B | $1.6B |
| Financing Cash Flow | $1.2B | $1.1B | $1.2B | $1.0B | $-0.3B | $1.1B | $0.5B | $0.7B |